GIBF is a Sino-Israeli investment fund established in 2016 and currently invests out of its second fund of $300m.

With a ticket size of $5-20m, we are looking to invest in innovative biotech companies around the globe.

Our focus is on drug development and delivery companies that are at clinical or approaching clinical stages of development and aspire to establish activities in China.The first fund of GIBF ($100m) has completed the investment period in 2021, investing in 12 medical device and digital health companies.